Cargando…
Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development
Receptor occupancy (RO) assays are designed to quantify the binding of therapeutics to their targets on the cell surface and are frequently used to generate pharmacodynamic (PD) biomarker data in nonclinical and clinical studies of biopharmaceuticals. When combined with the pharmacokinetic (PK) prof...
Autores principales: | Liang, Meina, Schwickart, Martin, Schneider, Amy K., Vainshtein, Inna, Del Nagro, Christopher, Standifer, Nathan, Roskos, Lorin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042057/ https://www.ncbi.nlm.nih.gov/pubmed/26054054 http://dx.doi.org/10.1002/cyto.b.21259 |
Ejemplares similares
-
Multiplexing of receptor occupancy measurements for pharmacodynamic biomarker assessment of biopharmaceuticals
por: Vainshtein, Inna, et al.
Publicado: (2015) -
Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4
por: Schwickart, Martin, et al.
Publicado: (2015) -
Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals
por: Vainshtein, Inna, et al.
Publicado: (2014) -
Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
por: Cheng, Jackie, et al.
Publicado: (2020) -
Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab
por: Wang, Bing, et al.
Publicado: (2017)